Navigation Links
Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects
Date:7/19/2011

BARCELONA, July 19, 2011 /PRNewswire/ --



• NT-KO-003, developed by Advancell and Neurotec Pharma, is the first MS drug with neuroprotective effects that does not cause immunosuppression.

• This treatment is one of the first to be administered orally, whereas the few treatments available in Spain require parenteral administration (intravenous or subcutaneous) and have significant side effects.

• NeuroAdvan, the Phase IIa clinical trial, will be led by Dr Pablo Villoslada, director of Neuroimmunology at IDIBAPS, Hospital Clínic de Barcelona, ??and conducted in 105 patients in 14 hospitals in Europe. It will  represent an investment of 2.2 M €, part of which will be financed by the Catalan Local Government and the Ministry of Science and Innovation.

• This project brings to clinical proof of concept the first molecule arising from Neurotec's research in the field of acute and chronic central nervous system diseases; Advancell reaffirms its business model consisting of the development of new drugs to Phase II, and to subsequently license them to a pharmaceutical company.

The biotechnological companies Advancell and Neurotec Pharma, both based in Barcelona Science Park (PCB), Spain, have announced the initiation of a clinical Phase IIa study with NT-KO-003, an innovative oral therapy for multiple sclerosis (MS). NT-KO-003 was codeveloped by both companies and its mechanism of action is completely different from the drugs currently used to treat this disease.

The clinical trial, called NeuroAdvan, will be conducted in 105 patients from 11 hospitals in Spain (4 of them in Catalonia) and 3 in Germany, and will be led by Dr Pablo Villoslada, director of Neuroimmunology at IDIBAPS, Hospital Clínic de Barcelona, Spain. The project is being conducted in collaboration with the MRI Analysis and Research Center in Neuroimaging and Multipl
'/>"/>

SOURCE Advancell
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802
2. BioNeutral Starts Commercial Deployment of Its Ygiene 206 Sterilant and Ogiene Products Within Port Authority Facilities Using T.U.C.S. Cleaning Services
3. AlloSource Starts Construction on New Campus
4. TriLink Awarded SBIR Phase I Grant: Thermally Activatable Probes and Cofactors for Hot Start Ligase Chain Reaction
5. Start-Up ImmusanT Seeks to Restore Tolerance to Gluten in Celiac Disease with Immunotherapy
6. Shionogi-ViiV Healthcare Starts Phase III Trial for 572-Trii Fixed-Dose Combination HIV Therapy
7. Start of the Ulm Helmholtz Institute
8. Terso Solutions RFID Jump Start Takes the Risk Out of Implementing RFID for Hospitals and Research Laboratories Looking to Streamline Operations and Improve Regulatory Compliance
9. Intel Corporation acquires Toronto start-up CognoVision
10. Midwest Health Care Startups Raise $572 Million Through Q3 2010
11. Leonhardts Launchpads at University of Northern California Incubator for Start Up Companies to Have Grand Opening Nov. 9th, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... SAN CARLOS, Calif. , March 3, 2015 /PRNewswire/ ... with expertise in drug-disease modeling and simulation research, today ... during the 2015 American Society for Clinical Pharmacology and ... March 3-7 2015.   Logo - ... and Rosa will present a poster describing a ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Becht ... today that it has acquired The CECON Group, ... the transaction were not announced. , Becht Engineering ... the energy sector including oil and gas production, ... fossil and nuclear power sectors. The company has ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/s3s3t8/personalized ... new report "Personalized Medicine - Scientific and ... The aim of personalized medicine or ... to the right patient and, in some cases, ... patient according to his/her genotype. This report describes ...
(Date:3/3/2015)... -- Johnson & Johnson Innovation LLC today announced the opening ... (JLABS @SSF), a 30,000-square foot incubator located at 329 ... The Johnson & Johnson Innovation, JLABS (JLABS) ... the healthcare spectrum including biotech, pharmaceutical, medical device, consumer ... startups have been selected, including the winners of the ...
Breaking Biology Technology:Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5
... Pharmacy has,announced that it will continue to ... who request it for their patients.,The announcement ... ) to stop supplying,Avastin directly to compounding ... is commonly administered by retinal specialists and,ophthalmologists ...
... CLAREMONT, Calif., Jan. 21 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech ... has,posted a video of portions of the ... year-end business review, planning for 2008,and employee ... senior managers:, Mr. Zhang, Director and ...
... hot chocolate present risk, OAKLAND, Calif., Jan. ... -- whether from coffee, tea, caffeinated soda or ... according a new study,by the Kaiser Permanente Division ... pregnancy-related symptoms of nausea, vomiting and caffeine,aversion that ...
Cached Biology Technology:Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists 2Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists 3Kiwa Posts Video of 2007 Annual Management Meetings 2Kiwa Posts Video of 2007 Annual Management Meetings 3Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 3Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 4
(Date:3/2/2015)... 2015  Businesses have a new option for ... Rankins Enterprises has announced the launch of a ... for businesses to protect their customers, personal data, ... Beconux is a biometric transaction processing system ... to an ATM machine, the new system fuses ...
(Date:2/24/2015)... 2015 This report analyzes the worldwide markets for Face ... Biometrics, and Voice Biometrics. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific , ... , and Latin America . Annual estimates and ... seven-year historic analysis is provided for these markets. Market data and ...
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
Breaking Biology News(10 mins):Personal Data Protection Company Launches New Product 2World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Cepheid to Webcast Upcoming Financial Presentations 2
... Stop wrangling over global warming and instead reduce fossil-fuel use ... from two scientists, one from the University of Washington and ... who say in the current issue of the journal ... flattening oil supply will trump the environment as a reason ...
... a study that holds major implications for breast cancer ... the U.S. Department of Energy (DOE),s Lawrence Berkeley National ... plays a critical role in the ability of breast ... gland known as acini. This rotation, which the researchers ...
... known for some time that house mice ( Mus musculus ... generally been assumed that these are no more than squeaks. ... and show features of song. Although the vocalizations are ... slowed down their similarity to bird song becomes striking. ...
Cached Biology News:Commentary in Nature: Can economy bear what oil prices have in store? 2Commentary in Nature: Can economy bear what oil prices have in store? 3Berkeley Lab researchers discover critical rotational motion in cells 2Berkeley Lab researchers discover critical rotational motion in cells 3Berkeley Lab researchers discover critical rotational motion in cells 4Tiny crooners: Male house mice sing songs to impress the girls 2
... combines enterprise-scale sequence analysis software with the DeCypher ... With DeCypher, you can perform searches like these ... NCBI NT database in under 6 days ... DNA Use HMM analysis to compare ...
...
Mouse polyclonal antibody to ALS2CR8 - amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8...
...
Biology Products: